Confirmation of IDH1 wild-type, O6-methylguanine-DNA-methyltransferase (MGMT) promoter-unmethylated GBM was made using R132 sequencing and methylation-specific PCR according to the 2016 World Health Organization criteria (46) after gross total resection (GTR). This evidence concerns the gene IDH1 and glioblastoma.